Literature DB >> 2066081

Effects of estradiol and progesterone on the sensitivity to pain and on morphine-induced antinociception in female rats.

A Ratka1, J W Simpkins.   

Abstract

Long-term ovariectomized (OVX) rats were exposed to 2- or 14-day replacement with pellets made of cholesterol (CHOL), estradiol (E2), progesterone (P4), or a combination of E2 and P4. Following the treatment with steroids the antinociceptive effect of morphine (5 mg/kg,sc) was measured by a hot-plate method. Pellets of E2 (0.5 and 5%) caused dose- and time-dependent reductions of morphine-induced antinociception as compared with OVX rats treated with CHOL pellets. Moreover, OVX rats pretreated with E2 pellets had decreased basic sensitivity to nociceptive stimulus (hyperalgesia). Treatment for 2 and 14 days with 75% P4 pellets produced significant reduction of MOR antinociception. The low dose of P4 (10% pellet) did not change the effect of MOR on Day 2 but significantly increased the antinociceptive effect of MOR on Day 14. Replacement of OVX rats with one 0.5% E2 pellet plus one 10% P4 pellet resulted in marked inhibition of the antinociceptive effect of MOR on Day 2 as well as on Day 14. Central injection 30 min before MOR of either LHRH antagonist or the antiserum against LHRH into OVX rats pretreated for 14 days with both steroids had no effect on the degree of the antinociception. The results suggest that the effects which ovarian steroids exert on opioid systems vary according to the dose, the duration of treatment, and the type of steroid administered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066081     DOI: 10.1016/0018-506x(91)90052-j

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  15 in total

1.  Sex differences in locomotor effects of morphine in the rat.

Authors:  Rebecca M Craft; James L Clark; Stephen P Hart; Megan K Pinckney
Journal:  Pharmacol Biochem Behav       Date:  2007-01-09       Impact factor: 3.533

2.  Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats.

Authors:  Erin C Stoffel; Catherine M Ulibarri; John E Folk; Kenner C Rice; Rebecca M Craft
Journal:  J Pain       Date:  2005-04       Impact factor: 5.820

3.  Ovariectomy modulation of morphine analgesia of neuropathic pain is associated with the change of K(+)-Cl(-) cotransporter 2 protein level in spinal dorsal horn.

Authors:  Weijun Shen; Liang Shen; Guoqiang Chen; Fen Wang; Cheng Li; Fuqing Lin; Xiaohu Yang; Shukun Fu
Journal:  Int J Clin Exp Med       Date:  2014-10-15

4.  Inactivation of the periaqueductal gray attenuates antinociception elicited by stimulation of the rat medial preoptic area.

Authors:  Yi-Hong Zhang; Matthew Ennis
Journal:  Neurosci Lett       Date:  2007-10-11       Impact factor: 3.046

5.  U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats.

Authors:  Anabel Puig-Ramos; Gladys S Santiago; Annabell C Segarra
Journal:  Behav Neurosci       Date:  2008-02       Impact factor: 1.912

6.  Are neuroactive steroids promising therapeutic agents in the management of acute and chronic pain?

Authors:  Vesna Jevtovic-Todorovic; Douglas F Covey; Slobodan M Todorovic
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

7.  Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke.

Authors:  Mustafa al'Absi; Lorentz E Wittmers; Dorothy Hatsukami; Ruth Westra
Journal:  Psychosom Med       Date:  2008-09-16       Impact factor: 4.312

8.  Androgen and estrogen (alpha) receptor localization on periaqueductal gray neurons projecting to the rostral ventromedial medulla in the male and female rat.

Authors:  Dayna R Loyd; Anne Z Murphy
Journal:  J Chem Neuroanat       Date:  2008-08-14       Impact factor: 3.052

9.  Pain in Times of Stress.

Authors:  Asma Hayati Ahmad; Rahimah Zakaria
Journal:  Malays J Med Sci       Date:  2015-12

Review 10.  Rapid pain modulation with nuclear receptor ligands.

Authors:  Jill C Fehrenbacher; Jesse Loverme; William Clarke; Kenneth M Hargreaves; Daniele Piomelli; Bradley K Taylor
Journal:  Brain Res Rev       Date:  2008-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.